Kintara Therapeutics's activity chart (see below) currently has 5 price targets and 8 ratings on display.
Analysts' price targets on this stock were met 25% of the time, taking 178.5 days on average.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 14-Jul-2023. First documented stock forecast 14-Aug-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 11-Nov-2022
3 years 4 months 8 days ago
(14-Jul-2023)
0/2 (0%)
$6912.5 (192.68%)
Buy Since 14-Sep-2020
$245
$10500
5 years 1 months 21 days ago
(01-Oct-2021)
1/2 (50%)
$-1207.5 (-83.13%)
357
What is KTRA (Kintara Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KTRA (Kintara Therapeutics)?
Which analyst has the lowest performance score on KTRA (Kintara Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KTRA (Kintara Therapeutics)?
Which analyst is the currently most bullish on KTRA (Kintara Therapeutics)?
Which analyst is the currently most reserved on KTRA (Kintara Therapeutics)?